Eli Lilly and Company company logo

# 1st Gen Model Eli Lilly and Company Pharmaceutical preparations

$86.21 Last close price
at 17-jan-2018

LLY

Model's trade recommendations No return for period yet

$95.77B Market Cap

β 0.35  

LLY

Model (following trade recommendations)

LLY

Underlying stock

S&P 500

Index
Return for period
0.15%
1.78%
52wk return
11.20%
16.82%
52wk Range
74.58—87.89
2000.54—2399.63
  • 2.08 (2.39%) Div (Yield)
  • BUY Analysts consensus recommendation

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Industry sector: Medical

Sector classification: Pharmaceutical preparations

Float 1099M
P/E 21.27
Shares Outstanding 1101M
% Held by Insiders 0.20%
% Held by Institutions 76.35%
EPS (last reported FY) $3.52
EPS (last reported Q) $1.05
EPS, estimated (last reported Q) $1.03
Total revenues $21 B
Net income $3 B